SEC Tracker
Get the app

Drugs Made In America Acquisition DMAA

Drugs Made In America Acquisition amends merger agreement with PAGC

Item 1.01 Enters material agreement, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. Amendment No. 1 to merger agreement dated Sept 8, 2026
  2. Closing Valuation reduced to $1.71B if APQC Acquisition not completed by Nov 1, 2026
  3. Fairness opinion now provided by Joel A. Gallo for Standalone Closing Valuation

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Drugs Made In America Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (6770) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Archimedes Tech SPAC Partners II ATII public float $235M, Jun 30, 2025
  2. Fifth Era Acquisition Corp I FERA public float $236M, Jun 30, 2025
  3. Sizzle Acquisition Corp. II SZZL public float $233M, Jun 30, 2025
  4. Jena Acquisition Corp II JENA public float $236M, Jun 30, 2025
  5. Rithm Acquisition RAC public float $237M, Mar 31, 2025, over 18 months old